Why is Lucid Diagnostics, Inc. ?
1
With a Negative Book Value, the company has a Weak Long Term Fundamental Strength
- Poor long term growth as Net Sales has grown by an annual rate of 39.90% and Operating profit at -245.14% over the last 5 years
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -49.47
2
Flat results in Jun 25
- OPERATING CASH FLOW(Y) Lowest at USD -43.06 MM
- DEBTORS TURNOVER RATIO(HY) Lowest at 16.36 times
3
Risky - Negative EBITDA
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of 11.18%, its profits have fallen by -5.6%
How much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Lucid Diagnostics, Inc. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Lucid Diagnostics, Inc.
10.22%
0.61
75.62%
S&P 500
13.22%
0.61
20.17%
Quality key factors
Factor
Value
Sales Growth (5y)
39.90%
EBIT Growth (5y)
-245.14%
EBIT to Interest (avg)
-49.47
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-1.57
Sales to Capital Employed (avg)
0.13
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
16.59%
ROCE (avg)
0
ROE (avg)
0
Valuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
-25.96
EV to EBIT
-3.10
EV to EBITDA
-3.16
EV to Capital Employed
48.49
EV to Sales
35.47
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-1564.48%
ROE (Latest)
Negative BV
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bullish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Bullish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
Technical Movement
5What is working for the Company
NET PROFIT(HY)
Higher at USD -23.71 MM
RAW MATERIAL COST(Y)
Fallen by -39.35% (YoY
EPS(Q)
Highest at USD -0.08
-4What is not working for the Company
OPERATING CASH FLOW(Y)
Lowest at USD -43.06 MM
DEBTORS TURNOVER RATIO(HY)
Lowest at 16.36 times
Here's what is working for Lucid Diagnostics, Inc.
Net Profit
Higher at USD -23.71 MM
than preceding 12 month period ended Jun 2025MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months
Net Profit (USD MM)
EPS
Highest at USD -0.08
in the last five periodsMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (USD)
Raw Material Cost
Fallen by -39.35% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Lucid Diagnostics, Inc.
Operating Cash Flow
Lowest at USD -43.06 MM and Fallen
In each year in the last three yearsMOJO Watch
The company's cash revenues from business operations are falling
Operating Cash Flows (USD MM)
Debtors Turnover Ratio
Lowest at 16.36 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling Debtors has slowed
Debtors Turnover Ratio






